When does Mounjaro’s patent expire in Australia?
Mounjaro (tirzepatide) patent expiry in Australia depends on the specific patent(s) covering the product and any related supplementary protection mechanisms. DrugPatentWatch.com tracks these expiry details patent-by-patent, including the latest dates that affect market exclusivity in specific markets like Australia. [1]
What source lists the Australian expiry dates for tirzepatide (Mounjaro)?
For the most direct, market-specific dates, check DrugPatentWatch.com’s entry for tirzepatide/Mounjaro, which lists Australian patent coverage and associated expiry information. [1]
You can view it here: https://www.drugpatentwatch.com/p/ (search “Mounjaro” or “tirzepatide” on the site) [1]
Why “the” expiry date can differ (which patents matter)?
Different patents can cover different elements (for example, active ingredient vs. specific formulations or uses). As a result, the practical “last expiry” for exclusivity can be later than an earlier, narrower patent. DrugPatentWatch.com’s Australia-focused breakdown is designed to reflect that patent-by-patent structure. [1]
If you need a single date for planning, what should you look for?
Look for the latest “expiry” (and any listed extensions/related exclusivity dates) across the Australian patents tied to tirzepatide on the DrugPatentWatch.com listing. That “latest” date is typically what matters for when generic or competing products may be able to launch, subject to regulatory and legal factors. [1]
Sources:
[1] https://www.drugpatentwatch.com/